tiprankstipranks
Trending News
More News >
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
US Market

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Income Statement

Compare
4 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Income Statement

Last quarter (Q4 2025), Guangzhou Baiyunshan Pharmaceutical Holdings Company's total revenue was ¥15.81B, a decrease of -0.75% from the same quarter last year. In Q4, Guangzhou Baiyunshan Pharmaceutical Holdings Company's net income was ¥-322.12M. See Guangzhou Baiyunshan Pharmaceutical Holdings Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 75.44B¥ 74.99B¥ 75.52B¥ 70.79B¥ 69.01B
Gross Profit
¥ 11.45B¥ 12.52B¥ 14.19B¥ 13.28B¥ 13.23B
Operating Expenses
¥ 8.43B¥ 8.92B¥ 9.07B¥ 8.73B¥ 8.85B
Depreciation and Amortization
¥ 931.11M¥ 875.24M¥ 929.44M¥ 743.83M¥ 676.99M
EBITDA
¥ 3.95B¥ 4.90B¥ 6.49B¥ 6.22B¥ 5.82B
Operating Income
¥ 3.02B¥ 3.60B¥ 5.12B¥ 5.07B¥ 4.79B
Other Income/Expenses
¥ 572.85M¥ 11.19M¥ -10.40M¥ -31.16M¥ -62.97M
Pretax Income
¥ 3.59B¥ 3.61B¥ 5.11B¥ 5.04B¥ 4.72B
Net Income
¥ 2.91B¥ 2.84B¥ 4.06B¥ 3.97B¥ 3.72B
Per Share Metrics
Basic EPS
¥ 1.79¥ 1.74¥ 2.49¥ 2.44¥ 2.29
Diluted EPS
¥ 1.79¥ 1.74¥ 2.49¥ 2.44¥ 2.29
Weighted Average Shares Outstanding
1.63B 1.63B 1.63B 1.63B 1.63B
Weighted Average Shares Outstanding (Diluted)
1.63B 1.63B 1.63B 1.63B 1.63B
Currency in CNY

Guangzhou Baiyunshan Pharmaceutical Holdings Company Earnings and Revenue History